According to IMARC Group latest report titled “T-cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on Global T-cell therapy market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global T-cell therapy market is expected to exhibit a CAGR of 16.9% during 2022-2027.
T-cell is an important part of the immune system and develops from bone marrow stem cells. It helps protect the body from infection and may help fight cancer. T-cell therapy is a procedure to get immune cells to fight cancer by changing them in the laboratory so they can find and kill cancer cells. It involves changing the genes inside T cells to help them fight cancer. It is very helpful in treating some types of cancer. It is also FDA-approved to treat several hematological malignancies, including leukemia, lymphoma, and multiple myeloma. T-Cell Therapy is also utilized to enhance the immune response against cancerous cells.
Request to Get the Free Sample Report: https://www.imarcgroup.com/t-cell-therapy-market/requestsample
Market Trends:
The global market is majorly driven by the increasing demand for ideal therapeutics for the treatment of cancer. In line with this, the rising prevalence of cancer worldwide is significantly contributing to market growth. Furthermore, the favorable reimbursement policies in several countries regarding CAR T-cell therapy are positively influencing the market. Apart from this, the growing incidences of lymphoma and leukemia are catalyzing the market. Moreover, the escalating approvals coupled with expanding manufacturing capabilities are propelling the market expansion. Besides, the heavy investments in research and development activities by the market players are favoring the market. Additionally, the increasing number of relapsed or refractory cancer cases showing response failure to alternative treatments such as chemotherapy and radiation therapy is providing a boost to the market.
Explore Full Report with Table of Contents: https://www.imarcgroup.com/t-cell-therapy-market
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
- Amgen Inc.
- Aurora Biopharma Inc.
- bluebird bio Inc
- Bristol-Myers Squibb Company
- Fate Therapeutics
- Gilead Sciences Inc.
- Merck KGaA
- Mustang Bio Inc.
- Novartis AG
- Pfizer Inc.
- Sorrento Therapeutics Inc.
- TCR2 Therapeutics
T-cell Therapy Market Segmentation:
Our report has categorized the market based on region, modality, therapy type and indication.
Breakup by Modality:
- Research
- Commercialized
Breakup by Therapy Type:
- CAR T-cell based
- T Cell Receptor (TCR) based
- Tumor Infiltrating Lymphocytes (TIL) based
Breakup by Indication:
- Hematologic Malignancies
- Lymphoma
- Leukemia
- Myeloma
- Solid Tumors
- Melanoma
- Brain and Central Nervous System
- Liver Cancer
- Others
- Others
Breakup by Region:
- North America (United States, Canada)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
